According to Biotest 's latest financial reports the company's current revenue (TTM) is $0.77 B. In 2022 the company made a revenue of $0.54 B a decrease over the years 2021 revenue that were of $0.59 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.77 B | 41.38% |
2022 | $0.54 B | -9.16% |
2021 | $0.59 B | 6.58% |
2020 | $0.56 B | 20% |
2019 | $0.46 B | -0.2% |
2018 | $0.46 B | 56.72% |
2017 | $0.29 B | -47.13% |
2016 | $0.56 B | -12.96% |
2015 | $0.65 B | -13.81% |
2014 | $0.75 B | 13.54% |
2013 | $0.66 B | 16.3% |
2012 | $0.57 B | -1.57% |
2011 | $0.58 B | 17.48% |
2010 | $0.49 B | -20.06% |
2009 | $0.61 B |